在2型糖尿病患者中,尿酸与可转移的糖尿病视网膜病变之间的关联
David Rivera-De-la-Parra1,2, Sergio Hernández-Jiménez2, Paloma Almeda-Valdés3
1Ophthalmology Department, Instituto de Oftalmología Conde de Valenciana IAP, Chimalpopoca 14, Colonia Obrera, Alcaldía Cuauhtémoc, 06800, Ciudad de México, México.
Scientific reports
|June 5, 2024
概括
尿酸 (UA) 水平升高与2型糖尿病患者患可转移性糖尿病视网膜病变 (DR) 的风险更高有关. 管理高尿血症可能有助于预防DR进展.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 血尿酸 (UA) 与糖尿病视网膜病变 (DR) 的相关性不一致.
- 具体的视力威胁DR阶段和UA联系仍未得到充分研究.
研究的目的:
- 调查2型糖尿病的墨西哥成年人血尿酸水平和可转移的糖尿病视网膜病变之间的关联.
主要方法:
- 对210名患有2型糖尿病 (T2D) 的墨西哥成年人的横截面研究.
- 临床,眼科和生化评估,包括 funduscopic 检查.
- 通过认证阅读器进行DR分期;对UA协会进行后勤回归分析.
主要成果:
- 可转移的DR患者的糖尿病持续时间更长,UA更高,血压更高,EGFR更低.
- 每增加1mg/dL的UA与可引用的DR的概率增加45%相关 (OR=1.45,P<0.01).
- UA水平≥7.8 mg/dL几乎使可参考DR的几率翻了一番 (OR=2.81,P=0.049).
结论:
- 血尿酸可能导致视网膜血管的微血管损伤.
- 超尿血可能是预防糖尿病视网膜病变进展的潜在治疗点.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Symptoms, Diagnosis, and Complications
523
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
523
Pathophysiology of Diabetes
920
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
920
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Management and Pharmacotherapy
260
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
260
Oral Hypoglycemic Agents: Biguanides and Glitazones
189
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
189


